Perricone Md Acne Relief Maximum Strength Spot Gel

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne. There are no teratogenic effects associated with its use, and no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer, which may be done one to three times daily.

Initially, it is advised to start with one application per day. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily if necessary.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once a day or every other day.

For new users, a sensitivity test is recommended. This involves applying the product sparingly to one or two small affected areas during the first three days. If no discomfort is experienced, the user may then proceed to follow the standard application instructions as outlined above.

Contraindications

Use is contraindicated in patients who experience irritation from topical acne medications. In such cases, it is advised to limit the use to one topical acne medication at a time to prevent exacerbation of irritation.

Warnings and Precautions

For external use only. It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

When utilizing this product, healthcare professionals should be aware that the risk of skin irritation and dryness may increase if another topical acne medication is used concurrently. To mitigate the potential for adverse effects, it is recommended that only one topical acne medication be employed at a time. If irritation does occur, the use of additional topical acne treatments should be discontinued.

Side Effects

For external use only. No specific adverse reactions or side effects have been reported in clinical trials or postmarketing experiences.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Perricone Md Acne Relief Maximum Strength Spot Gel (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the risk of teratogenic effects associated with its use. Pregnant women should avoid using this product unless directed by a healthcare provider. It is recommended that women who are pregnant or planning to become pregnant consult a healthcare professional before using this product to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is important to monitor renal function tests in these patients to ensure safety and efficacy. Additionally, a reduced dose should be considered for patients with decreased creatinine clearance to mitigate the risk of adverse effects.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, including airway management, oxygen supplementation, and intravenous fluids.

If the specific agent involved in the overdose is known, appropriate antidotes or treatments should be administered as per established guidelines. Continuous monitoring of the patient’s condition is crucial, and further interventions may be required based on the evolving clinical picture.

It is advisable for healthcare professionals to consult local poison control centers or toxicology experts for guidance on managing specific overdose cases. Documentation of the incident and any interventions performed is also critical for ongoing patient care and legal considerations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the use of this product may increase the likelihood of skin irritation and dryness, particularly if they are concurrently using another topical acne medication. It is essential to counsel patients to use only one topical acne medication at a time to minimize the risk of irritation. If patients experience any irritation, they should discontinue use and consult their healthcare provider for further guidance.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature, away from direct sunlight and moisture. To ensure safety, the product must be kept out of reach of children. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Patients should begin with one application daily and may gradually increase to two or three times daily as needed or directed by a clinician. In cases of bothersome dryness or peeling, it is advised to reduce the frequency to once a day or every other day.

Clinicians should counsel patients to use only one topical acne medication at a time if irritation occurs. The product should be kept out of reach of children, and in the event of ingestion, medical assistance or contact with a Poison Control Center is necessary. New users are advised to perform a sensitivity test by applying the product sparingly to one or two small affected areas for the first three days; if no discomfort arises, they may proceed with the standard application instructions.

Drug Information (PDF)

This file contains official product information for Perricone Md Acne Relief Maximum Strength Spot Gel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)